Genetic determinants of UV-susceptibility in Non-Melanoma Skin Cancer

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Welsh, Marleen M ^a   Karagas, Margaret R ^b   Kuriger, Jacquelyn K ^c   Houseman, Andres ^e   Spencer, Steven K ^f   Perry, Ann E ^f   Nelson, Heather H ^c,d  

^a Uniformed Services University of the Health Sciences   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e BROWN UNIVERSITY   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BURN; CANCER RISK; CONTROLLED STUDY; CUTANEOUS PARAMETERS; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAL GENE; HAPLOTYPE; HEREDITY; HRH2 GENE; HTR2A GENE; HUMAN; HUMAN TISSUE; IL10 GENE; IL12B GENE; IL4 GENE; IL4R GENE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONMELANOMA SKIN CANCER; ONCOGENE; PTGS2 GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TNF GENE; TNFR2 GENE; ULTRAVIOLET RADIATION; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGICAL TOLERANCE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; STATISTICAL MODEL;

ADULT; AGED; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNE TOLERANCE; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 79960094865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020019     Document Type: Article

References (47)

1. ACS (2005) Cancer Facts and Figures 2005. Atlanta American Cancer Society.
2. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA, (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81: 555-559.
3. Karagas MR, Martin A. Weinstock, Heather H. Nelson, (2006) Keratinocyte Carcinomas (Basal and Squamous Cell Carcinomas of the Skin). In: Schottenfeld DaJFF, editors. Cancer Epidemiology and Prevention, 3rd ed: Oxford University Press, USA.
4. Morison WL, Bucana C, Kripke ML, (1984) Systemic suppression of contact hypersensitivity by UVB radiation is unrelated to the UVB-induced alterations in the morphology and number of Langerhans cells. Immunology 52: 299-306.
5. Noonan FP, Bucana C, Sauder DN, De Fabo EC, (1984) Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies. J Immunol 132: 2408-2416.
6. Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, et al. (1992) UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A 89: 8497-8501.
7. Saijo S, Kodari E, Kripke ML, Strickland FM, (1996) UVB irradiation decreases the magnitude of the Th1 response to hapten but does not increase the Th2 response. Photodermatol Photoimmunol Photomed 12: 145-153.
8. Ullrich SE, Kripke ML, (1984) Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J Immunol 133: 2786-2790.
9. Jessup JM, Hanna N, Palaszynski E, Kripke ML, (1978) Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol 38: 105-115.
10. Noonan FP, Hoffman HA, (1994) Susceptibility to immunosuppression by ultraviolet B radiation in the mouse. Immunogenetics 39: 29-39.
11. Borchers A, Ansari AA, Hsu T, Kono DH, Gershwin ME, (2000) The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 29: 385-399.
12. Noonan FP, Muller HK, Fears TR, Kusewitt DF, Johnson TM, et al. (2003) Mice with genetically determined high susceptibility to ultraviolet (UV)-induced immunosuppression show enhanced UV carcinogenesis. J Invest Dermatol 121: 1175-1181.
13. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, et al. (1990) Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 95: 530-536.
14. Vermeer M, Schmieder GJ, Yoshikawa T, van den Berg JW, Metzman MS, et al. (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol 97: 729-734.
15. Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E, (2007) Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry 61: 167-173.
16. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, et al. (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43: 456-463.
17. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, et al. (1996) Gene polymorphism at position-308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett 215: 75-78.
18. Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, et al. (2001) Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum 44: 2819-2827.
19. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G, (2002) A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3: 419-423.
20. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8.
21. Zhang X, Miao X, Tan W, Ning B, Liu Z, et al. (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129: 565-576.
22. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, et al. (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25 Suppl 2: 74-78 discussion 95-76.
23. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y, et al. (1998) Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 19: 119-120.
24. Risma KA, Wang N, Andrews RP, Cunningham CM, Ericksen MB, et al. (2002) V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol 169: 1604-1610.
25. Andrews RP, Burrell L, Rosa-Rosa L, Cunningham CM, Brzezinski JL, et al. (2001) Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. Clin Immunol 100: 298-304.
26. Suchi M, Sano H, Mizuno H, Wada Y, (1995) Molecular cloning and structural characterization of the human histidase gene (HAL). Genomics 29: 98-104.
27. Welsh MM, Karagas MR, Applebaum KM, Spencer SK, Perry AE, et al. (2008) A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis.
28. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, et al. (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241: 252-261.
29. Breiman L, Jerome Friedman, Richard Olsen, Charles Stone, (1984) Classification and Regression Trees. Pacific Grove Wadsworth.
30. Steinberg DaPC, (1997) CART-Classification and Regression Trees. San Diego, CA Salford Systems.
31. Allen MH, Skov L, Barber R, Trembath R, Simon J, et al. (1998) Ultraviolet B induced suppression of induction of contact sensitivity in human skin is not associated with tumour necrosis factor-alpha-308 or interleukin-10 genetic polymorphisms. Br J Dermatol 139: 225-229.
32. Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F, (2003) Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 120: 99-103.
33. Wilkening S, Hemminki K, Rudnai P, Gurzau E, Koppova K, et al. (2006) Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol 155: 1139-1144.
34. de Oliveira WR, Rady PL, Grady J, Hughes TK, Festa Neto C, et al. (2003) Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol 49: 639-643.
35. Majewski S, Jablonska S, (1995) Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131: 1312-1318.
36. Nagano T, Kunisada M, Yu X, Masaki T, Nishigori C, (2008) Involvement of interleukin-10 promoter polymorphisms in nonmelanoma skin cancers-a case study in non-Caucasian skin cancer patients. Photochem Photobiol 84: 63-66.
37. Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, et al. (2002) Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 63: 690-695.
38. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, et al. (2002) Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 97: 2086-2092.
39. Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, et al. (2003) Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome. Ann Rheum Dis 62: 1117-1118.
40. Shreedhar V, Giese T, Sung VW, Ullrich SE, (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160: 3783-3789.
41. Balic A, Harcus YM, Taylor MD, Brombacher F, Maizels RM, (2006) IL-4R signaling is required to induce IL-10 for the establishment of T(h)2 dominance. Int Immunol 18: 1421-1431.
42. Wegmann TG, Lin H, Guilbert L, Mosmann TR, (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14: 353-356.
43. Salem ML, Matsuzaki G, Kishihara K, Madkour GA, Nomoto K, (2000) beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int Arch Allergy Immunol 121: 161-169.
44. Salem ML, Hossain MS, Nomoto K, (2000) Mediation of the immunomodulatory effect of beta-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-alpha and IFN-gamma. Int Arch Allergy Immunol 121: 235-245.
45. Matsushima GK, Gilmore W, Casteel N, Frelinger JA, Stohlman SA, (1989) Evidence for a subpopulation of antigen-presenting cells specific for the induction of the delayed-type hypersensitivity response. Cell Immunol 119: 171-181.
46. English DR, Armstrong BK, Kricker A, (1998) Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev 7: 857-863.
47. Rosso S, Minarro R, Schraub S, Tumino R, Franceschi S, et al. (2002) Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol 31: 439-446.